1366 related articles for article (PubMed ID: 8795138)
1. Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression.
Wang Z; Margulies L; Hicklin DJ; Ferrone S
Tissue Antigens; 1996 May; 47(5):382-90. PubMed ID: 8795138
[TBL] [Abstract][Full Text] [Related]
2. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
3. Reduced recognition of metastatic melanoma cells by autologous MART-1 specific CTL: relationship to TAP expression.
Murray JL; Hudson JM; Ross MI; Zhang HZ; Ioannides CG
J Immunother; 2000 Jan; 23(1):28-35. PubMed ID: 10687135
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of loss of HLA class I expression on colorectal tumor cells.
Browning M; Petronzelli F; Bicknell D; Krausa P; Rowan A; Tonks S; Murray N; Bodmer J; Bodmer W
Tissue Antigens; 1996 May; 47(5):364-71. PubMed ID: 8795136
[TBL] [Abstract][Full Text] [Related]
5. Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells.
Wang Z; Arienti F; Parmiani G; Ferrone S
Eur J Immunol; 1998 Sep; 28(9):2817-26. PubMed ID: 9754569
[TBL] [Abstract][Full Text] [Related]
6. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
[TBL] [Abstract][Full Text] [Related]
8. Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines.
Thor Straten P; Kirkin AF; Seremet T; Zeuthen J
Int J Cancer; 1997 Mar; 70(5):582-6. PubMed ID: 9052759
[TBL] [Abstract][Full Text] [Related]
9. Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
Chang CC; Campoli M; Restifo NP; Wang X; Ferrone S
J Immunol; 2005 Feb; 174(3):1462-71. PubMed ID: 15661905
[TBL] [Abstract][Full Text] [Related]
10. Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells.
Chang CC; Ogino T; Mullins DW; Oliver JL; Yamshchikov GV; Bandoh N; Slingluff CL; Ferrone S
J Biol Chem; 2006 Jul; 281(27):18763-73. PubMed ID: 16648140
[TBL] [Abstract][Full Text] [Related]
11. Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity.
Abdel-Wahab ZA; Osanto S; Darrow TL; Barber JR; Vervaert CE; Gangavalli R; McCallister TJ; Seigler HF
Cancer Gene Ther; 1994 Sep; 1(3):171-9. PubMed ID: 7621248
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes.
Arienti F; Sulé-Suso J; Melani C; Maccalli C; Belli F; Illeni MT; Anichini A; Cascinelli N; Colombo MP; Parmiani G
Hum Gene Ther; 1994 Sep; 5(9):1139-50. PubMed ID: 7833372
[TBL] [Abstract][Full Text] [Related]
13. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
[TBL] [Abstract][Full Text] [Related]
14. Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.
Corrias MV; Occhino M; Croce M; De Ambrosis A; Pistillo MP; Bocca P; Pistoia V; Ferrini S
Tissue Antigens; 2001 Feb; 57(2):110-7. PubMed ID: 11260505
[TBL] [Abstract][Full Text] [Related]
15. Nonclassical behavior of the thymus leukemia antigen: peptide transporter-independent expression of a nonclassical class I molecule.
Holcombe HR; Castaño AR; Cheroutre H; Teitell M; Maher JK; Peterson PA; Kronenberg M
J Exp Med; 1995 Apr; 181(4):1433-43. PubMed ID: 7699328
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the antigenic phenotype of human melanoma cells by differentiation-inducing and growth-suppressing agents.
Guarini L; Graham GM; Jiang H; Ferrone S; Zucker S; Fisher PB
Pigment Cell Res; 1992; Suppl 2():123-31. PubMed ID: 1357650
[TBL] [Abstract][Full Text] [Related]
17. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
[TBL] [Abstract][Full Text] [Related]
18. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
Jimenez P; Cantón J; Concha A; Cabrera T; Fernández M; Real LM; García A; Serrano A; Garrido F; Ruiz-Cabello F
Cancer Immunol Immunother; 2000 Mar; 48(12):684-90. PubMed ID: 10752476
[TBL] [Abstract][Full Text] [Related]
20. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
